Journey Medical (DERM) News Today $7.18 -0.09 (-1.17%) As of 01:54 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock DERM Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period HC Wainwright Predicts Journey Medical Q3 EarningsAugust 29 at 6:09 AM | marketbeat.comJourney Medical Corp Enters New Sales AgreementAugust 28 at 6:10 PM | tipranks.comJourney Medical (NASDAQ:DERM) Coverage Initiated at HC WainwrightAugust 27 at 8:26 AM | marketbeat.comJourney Medical (NASDAQ:DERM) Now Covered by HC WainwrightAugust 27 at 2:09 AM | americanbankingnews.comHC Wainwright & Co. Initiates Coverage of Journey Medical (DERM) with Buy RecommendationAugust 25, 2025 | msn.comJourney Medical initiated with a Buy at H.C. WainwrightAugust 25, 2025 | msn.comA Look At The Intrinsic Value Of Journey Medical Corporation (NASDAQ:DERM)August 25, 2025 | finance.yahoo.comJourney Medical Corporation (NASDAQ:DERM) Receives $10.83 Consensus Target Price from BrokeragesAugust 24, 2025 | americanbankingnews.comJourney Medical Corporation (NASDAQ:DERM) Receives Average Recommendation of "Moderate Buy" from BrokeragesAugust 21, 2025 | marketbeat.comQ3 Earnings Forecast for Journey Medical Issued By B. RileyAugust 19, 2025 | marketbeat.comQ3 Earnings Estimate for Journey Medical Issued By B. RileyAugust 19, 2025 | americanbankingnews.comJourney Medical Corporation to Present at the Emerging Growth Conference | DERM Stock NewsAugust 18, 2025 | gurufocus.comJourney Medical Corporation to Present at the Emerging Growth ConferenceAugust 18, 2025 | gurufocus.comJourney Medical Corporation to Present at the Emerging Growth ConferenceAugust 18, 2025 | globenewswire.comFY2027 EPS Estimates for Journey Medical Lowered by B. RileyAugust 17, 2025 | marketbeat.comFY2025 EPS Forecast for Journey Medical Decreased by AnalystAugust 17, 2025 | marketbeat.comAnalysts Issue Forecasts for Journey Medical Q4 EarningsAugust 16, 2025 | marketbeat.comJourney Medical (NASDAQ:DERM) Given New $13.00 Price Target at Lake Street CapitalAugust 15, 2025 | marketbeat.comJourney Medical (NASDAQ:DERM) Announces Quarterly Earnings Results, Misses Estimates By $0.10 EPSAugust 14, 2025 | marketbeat.comJourney Medical’s Earnings Call: EMROSI’s Impact and ChallengesAugust 14, 2025 | msn.comJourney Medical price target raised to $13 from $9 at Lake StreetAugust 13, 2025 | msn.comJourney Medical Corp (DERM) Q2 2025: Everything You Need To Know Ahead Of EarningsAugust 13, 2025 | finance.yahoo.comJourney Medical Corporation (DERM) Reports Q2 Loss, Beats Revenue EstimatesAugust 12, 2025 | msn.comJourney Medical targets sustained EMROSI momentum and profitability through 2025 as prescriber base nearly triplesAugust 12, 2025 | msn.comJourney Medical Corporation (DERM) Q2 2025 Earnings Call TranscriptAugust 12, 2025 | seekingalpha.comJourney Medical Corporation Reports Second Quarter 2025 Financial Results and Recent Corporate HighlightsAugust 12, 2025 | globenewswire.comJourney Medical Corporation Rings the Closing BellAugust 11, 2025 | nasdaq.comExamining the Future: Journey Medical's Earnings OutlookAugust 11, 2025 | benzinga.comJourney Medical Corporation to Ring Nasdaq Stock Market Closing Bell on August 11 | DERM Stock NewsAugust 7, 2025 | gurufocus.comJourney Medical Corporation to Ring Nasdaq Stock Market Closing Bell on August 11August 7, 2025 | gurufocus.comJourney Medical Corporation to Ring Nasdaq Stock Market Closing Bell on August 11August 7, 2025 | globenewswire.comJourney Medical Corporation to Announce Second Quarter 2025 Financial Results on August 12, 2025August 5, 2025 | globenewswire.comJourney Medical (DERM) to Release Quarterly Earnings on MondayAugust 5, 2025 | marketbeat.comJourney Medical Corporation (DERM) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 ReleaseAugust 4, 2025 | msn.comWhat is B. Riley's Estimate for Journey Medical Q2 Earnings?August 2, 2025 | marketbeat.comJourney Medical (NASDAQ:DERM) Coverage Initiated by Analysts at B. RileyJuly 31, 2025 | marketbeat.comJourney Medical Corporation Reports Increase in Payer Coverage for Emrosi™ to 65% of Commercial Lives, Supporting Growing Prescription DemandJuly 14, 2025 | quiverquant.comQJourney Medical Corporation Announces Expanded Payer Coverage for Emrosi™July 14, 2025 | globenewswire.comJourney Medical (NASDAQ:DERM) Rating Lowered to "Hold" at Wall Street ZenJuly 6, 2025 | marketbeat.comJourney Medical Corporation (DERM) - Yahoo FinanceJune 30, 2025 | finance.yahoo.comJourney Medical (NASDAQ:DERM) Stock Rating Upgraded by Wall Street ZenJune 28, 2025 | marketbeat.comJourney Medical Joins Russell 2000 and 3000 IndicesJune 24, 2025 | tipranks.comJourney Medical to Join Russell 2000® and Russell 3000® IndexesJune 24, 2025 | globenewswire.comJourney Medical announces data analysis from Phase 3 trials of EmrosiJune 21, 2025 | yahoo.comJourney Medical Corporation to Present Phase 3 Data on Emrosi™ for Rosacea at 2025 SDPA Summer ConferenceJune 20, 2025 | quiverquant.comQJourney Medical Corporation Announces Emrosi™ Data Analysis to be Presented at the Society of Dermatology Physician Associates (SDPA) 2025 Annual Summer Dermatology ConferenceJune 20, 2025 | globenewswire.comJourney Medical Corporation (NASDAQ:DERM) Short Interest Up 24.6% in MayJune 18, 2025 | marketbeat.comJourney Medical Co. (NASDAQ:DERM) Receives Average Rating of "Buy" from AnalystsJune 14, 2025 | marketbeat.comWall Street Zen Downgrades Journey Medical (NASDAQ:DERM) to HoldJune 14, 2025 | marketbeat.comJourney Medical Corporation Announces Emrosi™ Featured on “The Balancing Act” Airing on Lifetime TVJune 9, 2025 | globenewswire.com Get Journey Medical News Delivered to You Automatically Sign up to receive the latest news and ratings for DERM and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. DERM Media Mentions By Week DERM Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. DERM News Sentiment▼0.911.03▲Average Medical News Sentiment DERM News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. DERM Articles This Week▼173▲DERM Articles Average Week Get the Latest News and Ratings for DERM and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Journey Medical and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies Fortress Biotech News Today ProKidney News Today Theravance Biopharma News Today Immatics News Today Arbutus Biopharma News Today GH Research News Today KalVista Pharmaceuticals News Today Kura Oncology News Today Siga Technologies News Today Bicara Therapeutics News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:DERM) was last updated on 8/29/2025 by MarketBeat.com Staff From Our PartnersMusk’s Project Colossus could mint millionairesI predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Journey Medical Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share Journey Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access